Information  X 
Enter a valid email address

Silence Therapeutics PLC Ord5P (SLN)

Date Time Source Announcement
23 Jul 2019 11:27 am
RNS
Additional Listing
19 Jul 2019 4:35 pm
RNS
Price Monitoring Extension
  3:13 pm
RNS
Additional Listing
18 Jul 2019 11:46 am
RNS
Mallinckrodt to make equity investment in Silence
  11:45 am
RNS
Silence collaboration with Mallinckrodt
16 Jul 2019 11:46 am
RNS
Holding(s) in Company
28 Jun 2019 2:06 pm
RNS
Additional Listing
25 Jun 2019 12:09 pm
RNS
Result of AGM
24 Jun 2019 1:20 pm
RNS
Holding(s) in Company
21 Jun 2019 2:36 pm
RNS
Holding(s) in Company
20 Jun 2019 1:36 pm
RNS
Holding(s) in Company
  1:00 pm
RNS
Holding(s) in Company
19 Jun 2019 9:16 am
RNS
Holding(s) in Company
18 Jun 2019 4:37 pm
RNS
Holding(s) in Company
  4:37 pm
RNS
Holding(s) in Company
  1:37 pm
RNS
Holding(s) in Company
  12:28 pm
RNS
Additional Listing
28 May 2019 7:00 am
RNS
Collaboration with Genomics England
20 May 2019 4:46 pm
RNS
Additional Listing
14 May 2019 3:00 pm
RNS
Additional Listing
30 Apr 2019 7:00 am
RNS
Additional Listing
26 Apr 2019 2:35 pm
RNS
Additional Listing
25 Apr 2019 4:55 pm
RNS
Additional Listing
  7:00 am
RNS
Silence Therapeutics Announces Board Changes
18 Apr 2019 7:00 am
RNS
Appointment of Chief Financial Officer
  7:00 am
RNS
Silence Therapeutics Publication of Annual Report
16 Apr 2019 11:00 am
RNS
Silence Therapeutics Announces Board Change
  7:00 am
RNS
Silence Therapeutics appoints Head of R&D and CMO
04 Apr 2019 9:09 am
RNS
Holding(s) in Company
  9:09 am
RNS
Holding(s) in Company
27 Mar 2019 7:00 am
RNS
Silence Therapeutics submits CTA for SLN124
11 Mar 2019 7:00 am
RNS
2018 Preliminary Results
07 Mar 2019 7:00 am
RNS
Silence to Present at Cowen Healthcare Conference
05 Mar 2019 7:00 am
RNS
Notice of Results
04 Mar 2019 3:35 pm
RNS
Holding(s) in Company
  3:35 pm
RNS
Holding(s) in Company
26 Feb 2019 5:24 pm
RNS
Holding(s) in Company
  5:24 pm
RNS
Holding(s) in Company
01 Feb 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
15 Jan 2019 7:00 am
RNS
SLN124 granted Orphan Drug Designation by EMA
09 Jan 2019 7:00 am
RNS
Departure of Chief Financial Officer
19 Dec 2018 7:00 am
RNS
Silence Therapeutics advances next RNAi medicine
18 Dec 2018 4:35 pm
RNS
Price Monitoring Extension
10 Dec 2018 7:00 am
RNS
Settlement and License Agreement with Alnylam
12 Oct 2018 6:29 pm
RNS
Erratum: Results of Placing - Withdrawn
  5:12 pm
RNS
Results of Placing
11 Oct 2018 10:14 am
RNS
PTAB Upholds Silence Patent
10 Oct 2018 7:00 am
RNS
New divisional patent and injunction application
05 Oct 2018 2:16 pm
RNS
Holding(s) in Company
26 Sep 2018 7:00 am
RNS
Silence to Present at Healthcare Conference
21 Sep 2018 2:19 pm
RNS
Additional Listing
11 Sep 2018 7:00 am
RNS
Interim results for six months ended 30 June 2018
30 Aug 2018 10:53 am
RNS
Holding(s) in Company
  10:46 am
RNS
Holding(s) in Company
  10:46 am
RNS
Holding(s) in Company
24 Aug 2018 7:00 am
RNS
Notice of Results
20 Aug 2018 9:30 am
RNS
Silence Therapeutics Announces Board Change
07 Aug 2018 7:00 am
RNS
Litigation: patisiran EU MA imminent
17 Jul 2018 3:00 pm
RNS
Director/PDMR Shareholding
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t